DataMeds AI, Inc. (MEDS) stock
Close on Nov 17, 2026Market cap $1.96MP/E –Yield –
Earnings
DataMeds AI's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.
Quarterly results
Revenue and earnings per share from each of DataMeds AI's earnings releases, newest first
| Quarter | Reported | Revenue | YoY | EPS | Source |
|---|---|---|---|---|---|
| Q3 FY2026ended Sep 30, 2026 | Nov 13, 2026after the close | $2.70M | – | $2.72 | Release |
| Q2 FY2026ended Jun 30, 2026 | Aug 18, 2026before the open | $1.78M | – | -$7.13 | Release |
| Q1 FY2026ended Mar 31, 2026 | May 19, 2026after the close | $929.00K | – | – | Release |
| Q3 FY2025ended Sep 30, 2025 | Nov 20, 2025after the close | – | – | -$0.46 | Release |
| Q2 FY2025ended Jun 30, 2025 | Aug 22, 2025after the close | – | – | – | Release |
Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.
Current guidance
No open guidance: every period DataMeds AI guided for has been reported
Guidance vs results
The last range DataMeds AI gave before each report, against the figure it then reported. Full years add up the four quarters.
| Period | Metric | Guidance | Actual | Result |
|---|---|---|---|---|
| Q2 FY2026 | Revenue | $1.78M | $1.78M | Above range |
Guidance history
Every forecast DataMeds AI put in an earnings release, newest first
| Given | Metric | Period | Guidance | Change |
|---|---|---|---|---|
| May 19, 2026 | revenue | Q2 FY2026 | $1.78M | New |
Read from the company's earnings releases; each figure links to its sentence on hover. “Raised” and “Lowered” compare with the previous range for the same metric and period.
Press releases
Releases DataMeds AI filed with the SEC as exhibits to Form 8-K or 6-K
- Results
- Update
- Update
- Update
- Update
- Results
- News
- News
- News
- News
- News
- Update
- News
- Results
- Update
See a number that looks wrong?